TITLE

Involvement of nociceptin/orphanin FQ in release of hypothalamic GnRH mediated by ORL1 receptor in ovariectomized rats

AUTHOR(S)
Xiao-fei An; Hai-ping Chen; Shu-Ian Ma; Yi Feng; Jun-wei Had; Bo-ying Chen
PUB. DATE
September 2005
SOURCE
Acta Pharmacologica Sinica;Sep2005, Vol. 26 Issue 9, p1039
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
To investigate effect of the nociceptin/orphanin FQ (OFQ) on hypothalamus gonadotropin-releasing hormone (GnRH) release in ovariectomized (OVX) rats. GnRH radioimmunoassay (RIA) was used to study the effect of OFQ on GnRH release in hypothalamus slices in vitro. Push-pull perfusion and intracerebroventicular (icv) injection were used to examine the effect of OFQ on GnRH release in the hypothalamus medial preoptic area (POA) in vivo. Ovariectomies were performed on female Sprague-Dawley rats, and their plasma luteinizing hormone (LH) levels were measured after icv injection of OFQ with or without [Nphe1]NC(l-13)NH2,a competitive antagonist of opioid receptor-like 1 receptor (ORL1 receptor). Reverse transcription-polymerase chain reaction (RT-PCR) was used to investigate the expression of the ORL1 receptor in rat pituitary. Results: GnRH release from hypothalamus slices was inhibited 90 min after the administration of 2 mmol/L and 20 mmol/L OFQ ( P<0.05). Accordingly, GnRH release from hypothalamus POA was also significantly reduced by the injection of 0.2 mmol/L and 2 mmol/L OFQ. Plasma LH levels were also decreased significantly 2h after icv injection of 20 nmol OFQ in OVX rats ( P<0.05) and this effect could be abolished by pretreatment with 20 nmol [Nphe1]NC(1-13)NH2, that is, NC13. More interestingly, plasma LH levels in OVX rats increased markedly 2 h after icv injection of 100 nmol and 200 nmol NC13. RT-PCR analysis further revealed that the ORL1 receptor was not expressed in the pituitary of OVX rats. Central administration of nociceptin/orphanin FQ might inhibit the release of hypothalamic GnRH and decrease the plasma LH levels through ORL1 receptors in OVX rats.
ACCESSION #
18008928

 

Related Articles

  • Better Results from GnRH Agonist vs. GnRH Antagonist Cycles.  // Fertility Weekly;1/29/2007, p5 

    The article cites a research conducted by Robert Medved and colleagues to compare the results of frozen-thawed blastocysts resulting from cycles using controlled ovarian stimulation with GnRH agonists versus GnRH antagonists. The researchers concluded that frozen-thawed blastocysts obtained from...

  • Gonadotropin-releasing Factor/Hormone (GnRH).  // Encyclopedic Reference of Molecular Pharmacology;2004, p427 

    A definition of the term "gonadotropin-releasing factor/hormone (GnRH)" is presented. It is derived by proteolytic processing of a 92-amino acid precursor peptide to produce mature GnRH, a decapeptide. It is released from neurons in the hypothalamus. It discusses the GnRH pulse generator. The...

  • Gonadotropin-releasing Hormones.  // Encyclopedic Reference of Cancer;2001, p367 

    This entry provides the definition of the term "Gonadotropin-releasing Hormone." The term, also known as luteinizing hormone-releasing hormone, refers to a peptide hormone secreted from the hypothalamus. It stimulates the synthesis and release of luteinizing hormone and follicle-stimulating hormone.

  • releasing factors. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p655 

    A definition of the term "releasing factors" is presented. It refers to a group of hormones made by the hypothalamus in the brain to stimulate the release of other hormones. One such releasing factor is Luteinizing hormone-releasing hormone.

  • Clinical relevance for the fact that GnRH antagonists do not down-regulate the GnRH receptor. Gordon, Keith; Stegmann, Barbara J. // Human Reproduction;Apr2013, Vol. 28 Issue 4, p1144 

    No abstract available.

  • gonadorelin.  // Royal Society of Medicine: Medicines;2002, p272 

    This article presents information on gonadorelin, the hypothalamic hormone that acts on the pituitary gland to release the gonadotrophin hormones. It is therefore also known as luteinising hormone-releasing hormone. Gonadorelin is in fact the synthetic version of naturally occurring...

  • THE EFFECT OF GnRH AGONIST VERSUS GnRH ANTAGONIST ON PREGNANCY RATE. Bastu, Ercan; Baysal, Bulent // Acta Endocrinologica (1841-0987);Apr-Jun2012, Vol. 8 Issue 2, p249 

    Context. Comparison of GnRH analogues and their impact on IVF treatment to improve pregnancy outcome. Objective. To compare the effects of GnRH agonists and GnRH antagonists on pregnancy rates. Design. A total of 458 women who had embryo transfers completed were analyzed retrospectively in a...

  • LRF.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1363 

    A definition of the acronym LRF which stands for luteinizing hormone releasing factor is presented.

  • GnRH antagonist yields better results than GnRH agonist short protocol in case of failure with GnRH long protocol. Haruki, A.; Migishima, F.; Ito, K.; Oku, Y.; Morimoto, Y. // Reproductive BioMedicine Online (Reproductive Healthcare Limited;May2008 Supplement 2, Vol. 16 Issue S2, pS-19 

    Introduction: Gonadotrophin-releasing hormone (GnRH) antagonist has been applied in many centres, however the effectiveness of GnRH antagonist in ovarian stimulation is still controversial. In particular, it has not yet become evident whether GnRH antagonist or short GnRH agonist is more...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics